Holdings of ALPS Medical Breakthroughs ETF
ALPS ETF TRUST · Original filing · Compare with another fund · Report an error
- Net assets
- 161.8M $ including 161.8M $ in equities, 100.0 %
- Positions
- 82 in 8 countries
- Top ten
- 34.8 % of net assets
- Filed on
- May 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Alkermes PLC | 171,723 | 7.2M $ | 4.48 % |
| 2 | KYMERA THERAPEUTICS INC | 84,154 | 6.9M $ | 4.23 % |
| 3 | Celcuity Inc | 47,693 | 6.3M $ | 3.92 % |
| 4 | MIRUM PHARMACEUTICALS INC | 62,199 | 6.3M $ | 3.90 % |
| 5 | Spyre Therapeutics Inc | 80,958 | 6M $ | 3.68 % |
| 6 | CG ONCOLOGY INC | 87,032 | 5.4M $ | 3.35 % |
| 7 | Apogee Therapeutics Inc | 57,722 | 4.7M $ | 2.93 % |
| 8 | Xenon Pharmaceuticals Inc | 85,746 | 4.7M $ | 2.90 % |
| 9 | TRAVERE THERAPEUTICS INC | 95,051 | 4.5M $ | 2.77 % |
| 10 | Dianthus Therapeutics Inc | 45,839 | 4.3M $ | 2.64 % |
| 11 | NEWAMSTERDAM PHARMA COMPANY NV | 118,514 | 4M $ | 2.47 % |
| 12 | Viking Therapeutics Inc | 119,108 | 3.9M $ | 2.41 % |
| 13 | Crinetics Pharmaceuticals Inc | 107,892 | 3.8M $ | 2.37 % |
| 14 | ACADIA Pharmaceuticals Inc | 175,740 | 3.8M $ | 2.35 % |
| 15 | Edgewise Therapeutics Inc | 110,576 | 3.8M $ | 2.33 % |
| 16 | Denali Therapeutics Inc | 163,467 | 3.4M $ | 2.13 % |
| 17 | ORUKA THERAPEUTICS INC | 49,896 | 2.9M $ | 1.81 % |
| 18 | STRUCTURE THERAPEUTICS INC | 73,020 | 2.9M $ | 1.78 % |
| 19 | Disc Medicine Inc | 39,334 | 2.7M $ | 1.69 % |
| 20 | Ideaya Biosciences Inc | 90,520 | 2.7M $ | 1.65 % |
| 21 | VERA THERAPEUTICS INC | 73,552 | 2.6M $ | 1.61 % |
| 22 | TARSUS PHARMACEUTICALS INC | 43,870 | 2.6M $ | 1.61 % |
| 23 | Relay Therapeutics Inc | 184,224 | 2.6M $ | 1.60 % |
| 24 | Mineralys Therapeutics Inc | 81,578 | 2.6M $ | 1.59 % |
| 25 | Celldex Therapeutics Inc | 68,615 | 2.2M $ | 1.33 % |
| 26 | ZAI LAB LTD | 115,031 | 2M $ | 1.26 % |
| 27 | Pharvaris NV | 66,026 | 2M $ | 1.23 % |
| 28 | Sionna Therapeutics Inc | 46,379 | 2M $ | 1.23 % |
| 29 | Rapport Therapeutics Inc | 49,264 | 1.9M $ | 1.20 % |
| 30 | SAREPTA THERAPEUTICS INC | 108,222 | 1.9M $ | 1.20 % |
| 31 | Lakefront Biotherapeutics NV | 67,945 | 1.9M $ | 1.19 % |
| 32 | TYRA BIOSCIENCES INC | 55,509 | 1.9M $ | 1.15 % |
| 33 | Novavax Inc | 167,949 | 1.8M $ | 1.14 % |
| 34 | Stoke Therapeutics Inc | 58,873 | 1.8M $ | 1.12 % |
| 35 | Agios Pharmaceuticals Inc | 60,392 | 1.8M $ | 1.10 % |
| 36 | Vericel Corp | 52,309 | 1.7M $ | 1.08 % |
| 37 | Nuvation Bio Inc | 357,260 | 1.7M $ | 1.06 % |
| 38 | PALVELLA THERAPEUTICS INC | 14,096 | 1.7M $ | 1.03 % |
| 39 | Taysha Gene Therapies Inc | 282,348 | 1.7M $ | 1.02 % |
| 40 | AMYLYX PHARMACEUTICALS INC | 113,933 | 1.6M $ | 1.01 % |
| 41 | IMMATICS NV | 138,190 | 1.6M $ | 0.98 % |
| 42 | Immunocore Holdings PLC | 52,254 | 1.5M $ | 0.93 % |
| 43 | MBX BIOSCIENCES INC | 46,286 | 1.5M $ | 0.90 % |
| 44 | Bicara Therapeutics Inc | 65,313 | 1.4M $ | 0.88 % |
| 45 | MoonLake Immunotherapeutics | 73,934 | 1.4M $ | 0.88 % |
| 46 | KalVista Pharmaceuticals Inc | 52,105 | 1.4M $ | 0.87 % |
| 47 | ArriVent Biopharma Inc | 45,563 | 1.4M $ | 0.85 % |
| 48 | Oculis Holding AG | 58,929 | 1.4M $ | 0.84 % |
| 49 | Maze Therapeutics Inc | 49,602 | 1.3M $ | 0.81 % |
| 50 | MannKind Corp | 317,578 | 1.2M $ | 0.74 % |
| 51 | Corvus Pharmaceuticals Inc | 86,347 | 1.1M $ | 0.66 % |
| 52 | Olema Pharmaceuticals Inc | 81,077 | 1.1M $ | 0.66 % |
| 53 | ZENAS BIOPHARMA INC | 55,332 | 1M $ | 0.63 % |
| 54 | Kura Oncology Inc | 91,050 | 928.7K $ | 0.57 % |
| 55 | ARS Pharmaceuticals Inc | 102,352 | 928.3K $ | 0.57 % |
| 56 | Xencor Inc | 75,597 | 898.1K $ | 0.56 % |
| 57 | Theravance Biopharma Inc | 52,230 | 838.8K $ | 0.52 % |
| 58 | Geron Corp | 660,249 | 825.3K $ | 0.51 % |
| 59 | Design Therapeutics Inc | 63,568 | 666.2K $ | 0.41 % |
| 60 | Alto Neuroscience Inc | 32,025 | 642.7K $ | 0.40 % |
| 61 | Candel Therapeutics Inc | 75,500 | 626.7K $ | 0.39 % |
| 62 | Tectonic Therapeutic Inc | 19,353 | 603.1K $ | 0.37 % |
| 63 | Fulgent Genetics Inc | 32,191 | 583.9K $ | 0.36 % |
| 64 | Rigel Pharmaceuticals Inc | 19,042 | 580.6K $ | 0.36 % |
| 65 | Aclaris Therapeutics Inc | 124,304 | 565.6K $ | 0.35 % |
| 66 | Upstream Bio Inc | 55,699 | 465.6K $ | 0.29 % |
| 67 | Neurogene Inc | 15,968 | 452.5K $ | 0.28 % |
| 68 | Compass Therapeutics Inc | 185,633 | 441.8K $ | 0.27 % |
| 69 | Altimmune Inc | 134,076 | 408.9K $ | 0.25 % |
| 70 | Vanda Pharmaceuticals Inc | 60,925 | 393K $ | 0.24 % |
| 71 | Delcath Systems Inc | 35,814 | 386.1K $ | 0.24 % |
| 72 | Atea Pharmaceuticals Inc | 82,125 | 383.5K $ | 0.24 % |
| 73 | Zura Bio Ltd | 88,879 | 382.2K $ | 0.24 % |
| 74 | REGENXBIO Inc | 53,200 | 372.9K $ | 0.23 % |
| 75 | Rezolute Inc | 98,643 | 325.5K $ | 0.20 % |
| 76 | Anavex Life Sciences Corp | 95,522 | 289.4K $ | 0.18 % |
| 77 | Akebia Therapeutics Inc | 276,121 | 281.6K $ | 0.17 % |
| 78 | Protara Therapeutics Inc | 55,748 | 259.2K $ | 0.16 % |
| 79 | Forte Biosciences Inc | 12,912 | 246.2K $ | 0.15 % |
| 80 | BICYCLE THERAPEUTICS PLC | 51,450 | 241.3K $ | 0.15 % |
| 81 | Arcturus Therapeutics Holdings Inc | 29,289 | 232K $ | 0.14 % |
| 82 | Aardvark Therapeutics Inc | 22,439 | 92.2K $ | 0.06 % |
Sector breakdown
- Unattributed 100.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 83.4 %
- Netherlands 4.7 %
- Ireland 4.5 %
- Canada 2.9 %
- Cayman Islands 2.4 %
- Belgium 1.2 %
- Switzerland 0.8 %
- United Kingdom 0.1 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 71 | 135M $ | 83.40 % |
| 2 | Netherlands | 3 | 7.6M $ | 4.68 % |
| 3 | Ireland | 1 | 7.2M $ | 4.48 % |
| 4 | Canada | 1 | 4.7M $ | 2.90 % |
| 5 | Cayman Islands | 3 | 3.8M $ | 2.37 % |
| 6 | Belgium | 1 | 1.9M $ | 1.19 % |
| 7 | Switzerland | 1 | 1.4M $ | 0.84 % |
| 8 | United Kingdom | 1 | 241.3K $ | 0.15 % |
Cite this page
Titelia. "Holdings of ALPS Medical Breakthroughs ETF". https://titelia.com/en/funds/S000047823